Pharmaceutical Industry Information Portal

HomePharma marketing analytics

Pharma marketing analytics

RNC Pharma: Product Range and Promotion Changes in Store for Pharmaceutical Retail in First Half of 2023

Last year, the Russian pharmaceutical retail industry went through a long period of stress, from the spring rush demand to demand plummeting in the...

RNC Pharma: Pharmaceutical Drug Production in Russia (December 2022)

In 2022, Russian manufacturers produced 668.8 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), up 7.1% from 2021. In physical terms,...

RNC Pharma: API Import to Russia in 2022

In 2022, Russia imported 191.6 billion rubles’ worth of APIs (customs clearance and VAT included), down 4.2% from 2021 for the first time in...

Hikma Pharmaceuticals down 30%, stock to buy on fall

Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was founded in 1978. Over the...

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by a low-to-mid twenties percentage, but...
spot_img

Expert Articles

spot_img